Aggie
Lv1
30 积分
2021-03-14 加入
-
Design of Clinical Trials for Mild to Moderate Ulcerative Colitis
4天前
已完结
-
Application of Model‐Informed Drug Development in Dose Selection and Optimization for siRNA Therapies
29天前
已完结
-
Serious adverse events of Inclisiran in patients with hypercholesterolemia, a meta analysis of ORION trials
2个月前
已完结
-
Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomised, multicentre, double-blind, phase 3 trial
4个月前
已完结
-
Elimination of Off-Target Effect by Chemical Modification of 5′-End of siRNA
7个月前
已完结
-
Metabolically Stable Anomeric Linkages Containing GalNAc–siRNA Conjugates: An Interplay among ASGPR, Glycosidase, and RISC Pathways
7个月前
已完结
-
First-in-human randomized study of RNAi therapeutic RG6346 for chronic hepatitis B virus infection
7个月前
已完结
-
Targeted delivery of oligonucleotides using multivalent protein–carbohydrate interactions
7个月前
已完结
-
First-in-human randomized study of RNAi therapeutic RG6346 for chronic hepatitis B virus infection
8个月前
已完结
-
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial
8个月前
已完结